ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.97
0.13%
US Tech 100
20,534.40
-0.37%
S&P 500
5,918.25
0.00%
US Dollar vs CAD
1.44089
0.05%
Bitcoin
94,778.13
2.56%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. INVO BioScience Inc (INVO)

  7. INVO BioScience Inc (INVO) News

INVO

INVO BioScience (INVO)

INVO BioScience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INVO
DateTimeSourceHeadlineSymbolCompany
10/24/20248:00AMGlobeNewswire Inc.NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular CarcinomaNASDAQ:INVOINVO BioScience Inc
10/22/202411:05AMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:INVOINVO BioScience Inc
10/21/20248:00AMGlobeNewswire Inc.INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA BiosciencesNASDAQ:INVOINVO BioScience Inc
10/15/20248:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
10/14/20248:18AMGlobeNewswire Inc.INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)NASDAQ:INVOINVO BioScience Inc
10/01/20244:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
09/20/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
09/18/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
08/14/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
08/14/20248:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVOINVO BioScience Inc
08/14/20248:00AMGlobeNewswire Inc.INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDANASDAQ:INVOINVO BioScience Inc
05/21/20243:39PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INVOINVO BioScience Inc
05/15/20243:51PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
05/15/20243:15PMGlobeNewswire Inc.INVO Reports Record First Quarter 2024 Financial ResultsNASDAQ:INVOINVO BioScience Inc
05/06/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
04/17/20249:25AMAllPennyStocks.comMicro Cap Massively Bid Up Before Opening BellNASDAQ:INVOINVO BioScience Inc
04/16/20243:59PMGlobeNewswire Inc.INVO Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:INVOINVO BioScience Inc
02/06/20249:24AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVOINVO BioScience Inc
02/01/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
01/23/20247:00AMGlobeNewswire Inc.NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)NASDAQ:INVOINVO BioScience Inc
01/17/20247:00AMGlobeNewswire Inc.INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board DirectorsNASDAQ:INVOINVO BioScience Inc
01/16/20244:29PMEdgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:INVOINVO BioScience Inc
01/10/20243:46PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:INVOINVO BioScience Inc
01/10/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
01/03/20244:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
12/28/20234:04PMEdgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:INVOINVO BioScience Inc
12/28/20234:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
12/13/20234:08PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INVOINVO BioScience Inc
12/13/20233:53PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
12/11/20237:00AMPR Newswire (US)NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood JournalNASDAQ:INVOINVO BioScience Inc
 Showing the most relevant articles for your search:NASDAQ:INVO

Your Recent History

NASDAQ
LWLG
Lightwave Logic
NASDAQ
AMRN
Amarin
USOTC
BIEL
Bioelectronics (PK)
COIN
XRPUSD
Ripple
USOTC
MONI
Moon Equity (PK)
USOTC
NBRI
North Bay Resources (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
RNVA
Rennova Health (CE)
NASDAQ
TNXP
Tonix Pharmaceuticals
NASDAQ
TSLA
Tesla
NASDAQ
AVXL
Anavex Life Sciences
USOTC
TGLO
TheGlobe com (PK)
USOTC
GTCH
GBT Technologies (PK)
NYSE
IONQ
IonQ
USOTC
AABB
Asia Broadband (PK)
USOTC
FNMA
Fannie Mae (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads